Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: ILExchange: Nasdaq
DilutionScan read 43 of Pluri Inc.'s SEC filings and found 10 warrant series, 2 convertibles, 1 ATM program, 3 shelf registrations, 1 S-1 registration and 5 completed offerings on file for PLUR. Analysis updated Oct 31, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
ESLAEstrella Immunopharma, Inc.
JSPRJasper Therapeutics, Inc.
HEPAHepion Pharmaceuticals, Inc.
AEONAEON Biopharma, Inc.
ABOSAcumen Pharmaceuticals, Inc.
KYNBKyntra Bio, Inc.
BOLTBolt Biotherapeutics, Inc.
ALLRAllarity Therapeutics, Inc.
NEUPNeuphoria Therapeutics Inc.
QNTMQuantum BioPharma Ltd.
MRKRMarker Therapeutics, Inc.
ATYRaTyr Pharma, Inc.
MCRBSeres Therapeutics, Inc.
CNTXContext Therapeutics Inc.
AKTXAkari Therapeutics, Plc